Open- | Close- |
Vol / Avg.167.975K / 2.391M | Mkt Cap10.874M |
Day Range- - - | 52 Wk Range0.134 - 3.460 |
Brainstorm Cell Stock (NASDAQ: BCLI) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.167.975K / 2.391M | Mkt Cap10.874M |
Day Range- - - | 52 Wk Range0.134 - 3.460 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.140 | -0.030 | 0.1100 | ||||
REV | 0 |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.150 | -0.130 | 0.0200 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-28 | Maxim Group | Jason McCarthy | Downgrades | BuyHold | - | - | - |
2023-03-31 | Maxim Group | Jason McCarthy | Maintains | Buy | Lowers | 5.00 | 10.00 |
2021-02-05 | Maxim Group | Jason McCarthy | Upgrades | HoldBuy | - | - | - |
2018-05-15 | HC Wainwright & Co. | - | Initiates Coverage On | Buy | Announces | - | 11.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
BCLI | Brainstorm Cell | 0.91% | 10.9M |
IMPL | Impel Pharmaceuticals | -7.9% | 11.5M |
IMRN | Immuron | 0% | 11.5M |
VIRI | Virios Therapeutics | 5.98% | 11.6M |
DOMH | Dominari Holdings | -7.11% | 11M |
You can purchase shares of Brainstorm Cell (NASDAQ: BCLI) through any online brokerage.
Other companies in Brainstorm Cell’s space includes: Impel Pharmaceuticals (NASDAQ:IMPL), Immuron (NASDAQ:IMRN), Virios Therapeutics (NASDAQ:VIRI), Dominari Holdings (NASDAQ:DOMH) and Imunon (NASDAQ:IMNN).
The latest price target for Brainstorm Cell (NASDAQ: BCLI) was reported by Maxim Group on Thursday, September 28, 2023. The analyst firm set a price target for 0.00 expecting BCLI to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
The stock price for Brainstorm Cell (NASDAQ: BCLI) is $0.222 last updated Today at November 30, 2023 at 2:16 PM UTC.
There is no dividend information for Brainstorm Cell.
Brainstorm Cell’s Q3 earnings are confirmed for Tuesday, November 14, 2023.
There is no upcoming split for Brainstorm Cell.
Brainstorm Cell is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.